National Healthcare Disparities Report - LDI Health Economist
National Healthcare Disparities Report - LDI Health Economist
National Healthcare Disparities Report - LDI Health Economist
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Effectiveness of Care<br />
Treatment: Recommended Care for Breast Cancer<br />
Different diagnostic and treatment options exist for various types of cancer. Some aspects of cancer care are<br />
well established as beneficial and are commonly recommended. The appropriateness of recommended care<br />
depends on different factors, such as the stage or extent of the cancer within the body (especially whether the<br />
disease has spread from the original site to other parts of the body). Other types of care are important for<br />
accurate diagnosis, such as ensuring adequate examination of lymph nodes when surgery is performed.<br />
Figure 2.3. Women with clinical Stage I-IIb breast cancer who received axillary node dissection or<br />
sentinel lymph node biopsy at the time of lumpectomy or mastectomy, by race and ethnicity, 2004-2008<br />
Chapter 2 Cancer<br />
100 White Black<br />
95<br />
90<br />
NHOPI<br />
2008 Achievable<br />
Benchmark: 97%<br />
AI/AN<br />
Asian<br />
100<br />
95<br />
90<br />
Total Non-Hispanic White<br />
Hispanic<br />
2008 Achievable Benchmark: 97%<br />
Percent<br />
85<br />
Percent<br />
85<br />
80<br />
80<br />
75<br />
Z<br />
0<br />
2004<br />
2005<br />
2006<br />
2007<br />
2008<br />
75<br />
Z<br />
0<br />
2004<br />
2005<br />
2006<br />
2007<br />
2008<br />
Key: NHOPI = Native Hawaiian or Other Pacific Islander; AI/AN = American Indian or Alaska Native.<br />
Source: Commission on Cancer, American College of Surgeons and American Cancer Society, <strong>National</strong> Cancer Data Base, 2004-2008.<br />
Denominator: Women with Stage I-IIb breast cancer undergoing lumpectomy or mastectomy.<br />
n The percentage of women with clinical Stage I-IIb breast cancer who received axillary node<br />
dissection or sentinel lymph node biopsy at the time of lumpectomy or mastectomy increased from<br />
85% in 2004 to 94% in 2008 (Figure 2.3). Significant improvement was observed among all racial<br />
and ethnic groups except AI/ANs.<br />
n In all years, Asian women were more likely than White women to receive axillary node dissection or<br />
sentinel lymph node biopsy.<br />
n The 2008 top 5 State achievable benchmark was 97%. vi At the current rate of increase, most women<br />
could achieve the benchmark in 1 year.<br />
vi<br />
The top 5 States contributing to the achievable benchmark are Minnesota, Mississippi, Nevada, Oklahoma, and South Dakota.<br />
54 <strong>National</strong> <strong><strong>Health</strong>care</strong> <strong>Disparities</strong> <strong>Report</strong>, 2011